Dynavax Technologies Corp (NASDAQ:DVAX)

23.58
Delayed Data
As of Apr 17
 -0.58 / -2.40%
Today’s Change
12.50
Today|||52-Week Range
26.89
+39.86%
Year-to-Date

Today’s Trading

Previous close24.16
Today’s open23.88
Day’s range22.96 - 23.95
Volume459,584
Average volume (3 months)440,160
Market cap$681.8M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-3.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book6.17

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+0.09+0.25%
AMPHAmphastar Pharmaceut...-0.20-1.31%
VTLVital Therapies Inc-0.70-2.54%
CORTCorcept Therapeutics...-0.07-1.16%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers